A

Agilent Technologies, Inc. [A] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

A Stock Summary

Top A Correlated Resources

A


Top 10 Correlated ETFs

A


Top 10 Correlated Stocks

A


In the News

02:55 10 Dec 2023 A

Agilent Technologies, Inc. (A) Evercore ISI HealthCONx Conference 2023 Transcript

Agilent Technologies, Inc. (NYSE:A ) Evercore ISI HealthCONx Conference 2023 November 29, 2023 10:50 AM ET Company Participants Mike McMullen - President and Chief Executive Officer Bob McMahon - Chief Financial Officer Conference Call Participants Vijay Kumar - Evercore ISI Vijay Kumar Thanks everyone for joining us this morning. I'm Vijay Kumar.

11:25 10 Dec 2023 A

Why I Made Big Changes To My Dividend Growth Portfolio

I've made significant changes to my portfolio due to buying a new house and selling stocks from my portfolio to raise cash. My goal is to prioritize building a passive income stream, but I recognize the value of investing in a new home for improved quality of life. In this article, I discuss different options to pay for the new home, including taking out a mortgage or selling more stock if mortgage rates remain high.

09:30 10 Dec 2023 A

Earn A Potential 10% Plus Income With Options (December 2023)

We explain why selling cash-covered puts and covered calls are relatively safe choices for earning a high income. We will discuss how to formulate a sustainable and repeatable options income strategy. In this monthly series, we present how to go about selecting the right kind of stocks for options income. We present two lists of 10 stocks with multiple scenarios: PUT options, CALL options, and deep-in-the-money CALL options.

07:00 10 Dec 2023 A

Down 24% This Year Will Agilent Technologies Stock Rebound To Its Pre-Inflation High Of $175?

The company's top line has contracted in the recent past due to lower sales in China.

02:17 10 Dec 2023 A

Agilent (A) Q4 Earnings & Revenues Beat Estimates, Down Y/Y

Agilent's (A) fourth-quarter fiscal 2023 results are hurt by weakness in the LSAG segment and softness in the China market.

07:33 10 Dec 2023 A

Agilent (A) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Agilent (A) give a sense of how its business performed in the quarter ended October 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

07:23 10 Dec 2023 A

Agilent Technologies, Inc. (A) Q4 2023 Earnings Call Transcript

Agilent Technologies, Inc. (NYSE:A ) Q4 2023 Earnings Conference Call November 20, 2023 4:30 PM ET Company Participants Parmeet Ahuja - IR Mike McMullen - President and CEO Robert McMahon - SVP and CFO Sam Raha - President, Agilent Diagnostics & Genomics Group Padraig McDonnell - President, Agilent CrossLab Group Phil Binns - President of the Agilent Life Sciences and Applied Markets Group Conference Call Participants Vijay Kumar - Evercore ISI Patrick Donnelly - Citigroup Inc. Matt Sykes - Goldman Sachs Rachel Vatnsdal - JPMorgan Derik De Bruin - Bank of America Jack Meehan - Nephron Research Puneet Souda - Leerink Partners Josh Waldman - Cleveland Research Daniel Brennan - TD Cowen Dan Leonard - UBS Operator Ladies and gentlemen, welcome to the Agilent Technologies Q4 2023 Earnings Conference Call. My name is Bo and I will be coordinating your call today.

04:47 10 Dec 2023 A

Agilent Technologies stock higher as 4Q results beat estimates

Agilent Technologies (NYSE:A) Inc after Monday's close announced fourth quarter 2023 financial results that exceeded expectations on both the top and bottom lines.  The analytical and clinical laboratory technologies provider's adjusted earnings per share (EPS) for the period declined 10% year over year to $1.38, while its revenue fell 9% to $1.69 billion.

03:06 10 Dec 2023 A

3 Biotech Stocks With Big-Time Breakthrough Potential

In a world in constant evolution and growth, more and more companies are needed that are committed to development and research in the health area. These biotech companies are not only doing the job, but also have potential for future growth.

02:26 10 Dec 2023 A

Earnings Exchange: Medtronic, Agilent Technologies & Trip.com

Ari Wald, managing director and head of technical analysis at Oppenheimer, joins 'The Exchange' to discuss Medtronic, Agilent Technologies, and Trip.com.

A Financial details

Company Rating
Strong Buy
Market Cap
37.22B
Income
1.24B
Revenue
6.83B
Book val./share
20.02
Cash/share
5.45
Dividend
0.9
Dividend %
0.71%
Employees
18K
Optionable
No
Shortable
Yes
Earnings
26 Feb 2024
P/E
29.95
Forward P/E
22.36
PEG
418.3
P/S
5.45
P/B
6.35
P/C
23.34
P/FCF
25.25
Quick Ratio
1.8
Current Ratio
2.61
Debt / Equity
0.47
LT Debt / Equity
0.47
-
-
EPS (TTM)
4.22
EPS next Y
5.69
EPS next Q
1.3
EPS this Y
0.72%
EPS next Y
34.83%
EPS next 5Y
51.66%
EPS last 5Y
4.35%
Revenue last 5Y
5.76%
Revenue Q/Q
0.96%
EPS Q/Q
328.95%
-
-
-
-
SMA20
19.42%
SMA50
14.72%
SMA100
6.39%
Inst Own
56.2%
Inst Trans
0.66%
ROA
12%
ROE
22%
ROC
0.15%
Gross Margin
51%
Oper. Margin
20%
Profit Margin
18%
Payout
21%
Shs Outstand
292.59M
Shs Float
291.34M
-
-
-
-
Target Price
149.33
52W Range
96.8-160.26
52W High
-20.5%
52W Low
+32.5%
RSI
66.93
Rel Volume
0.67
Avg Volume
2.14M
Volume
1.44M
Perf Week
-0.31%
Perf Month
21.94%
Perf Quarter
7.65%
Perf Half Y
9.1%
-
-
-
-
Beta
1.1
-
-
Volatility
0.62%, 9.8%
Prev Close
-1.15%
Price
127.2
Change
-1.55%

A Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-10-31

Metric History 2019-10-312020-10-312021-10-312022-10-31 2023-10-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
16.4417.2820.7922.923.24
Net income per share
3.412.333.984.194.22
Operating cash flow per share
3.252.984.884.396.03
Free cash flow per share
2.752.64.263.415.01
Cash per share
4.44.665.183.525.41
Book value per share
15.1215.7717.7317.6919.88
Tangible book value per share
-3.37-1.27-1.8-1.024.8
Share holders equity per share
15.1215.7717.7317.6919.88
Interest debt per share
7.97.899.249.549.63
Market cap
23.79B31.55B47.75B41.37B30.39B
Enterprise value
24.81B32.46B48.99B43.08B31.54B
P/E ratio
22.2143.8739.4632.9924.51
Price to sales ratio
4.615.917.566.044.45
POCF ratio
23.334.2532.1531.5317.15
PFCF ratio
27.539.3336.8440.5220.62
P/B Ratio
5.016.478.867.825.2
PTB ratio
5.016.478.867.825.2
EV to sales
4.816.087.756.294.62
Enterprise value over EBITDA
20.1526.4427.822.6218.5
EV to operating cash flow
24.335.2532.9932.8417.8
EV to free cash flow
28.6840.4837.842.221.39
Earnings yield
0.050.020.030.030.04
Free cash flow yield
0.040.030.030.020.05
Debt to equity
0.510.480.510.520.47
Debt to assets
0.250.250.250.260.25
Net debt to EBITDA
0.830.750.710.90.67
Current ratio
1.532.332.222.032.61
Interest coverage
12.7210.8516.6319.2614.21
Income quality
0.951.281.231.051.43
Dividend Yield
0.010.0100.010.01
Payout ratio
0.190.310.20.20.21
Sales general and administrative to revenue
00000
Research and developement to revenue
0.080.090.070.070.07
Intangibles to total assets
0.50.460.460.450.41
Capex to operating cash flow
-0.15-0.13-0.13-0.22-0.17
Capex to revenue
-0.03-0.02-0.03-0.04-0.04
Capex to depreciation
-0.66-0.39-0.59-0.92-1.1
Stock based compensation to revenue
0.010.020.020.020.02
Graham number
34.0728.7339.8440.8643.44
ROIC
0.150.10.150.170.15
Return on tangible assets
0.230.140.210.220.2
Graham Net
-7.28-7.04-8.05-8.7-6.27
Working capital
1.11B1.95B2.09B1.92B2.58B
Tangible asset value
48M440M433M516M1.41B
Net current asset value
-1.52B-1.34B-1.52B-1.45B-732M
Invested capital
0.510.480.510.520.47
Average receivables
853M984M1.11B1.29B1.35B
Average payables
347M354M400M513M499M
Average inventory
658.5M699.5M775M934M1.03B
Days sales outstanding
65.7570.9667.774.8968.96
Days payables outstanding
54.851.6455.967.7245.3
Days of inventory on hand
105.1105.04104.04121.2111.73
Receivables turnover
5.555.145.394.875.29
Payables turnover
6.667.076.535.398.06
Inventory turnover
3.473.483.513.013.27
ROE
0.230.150.220.240.21
Capex per share
-0.5-0.39-0.62-0.97-1.01

Quarterly Fundamentals Overview

Last date of statement is 2023-10-31 for Q4

Metric History 2022-10-312023-01-312023-04-302023-07-31 2023-10-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
6.255.935.85.695.78
Net income per share
1.241.191.020.381.63
Operating cash flow per share
1.5111.341.911.77
Free cash flow per share
1.280.741.151.641.48
Cash per share
3.564.253.974.525.45
Book value per share
17.8718.9519.5318.920.02
Tangible book value per share
-1.030.023.393.654.83
Share holders equity per share
17.8718.9519.5318.920.02
Interest debt per share
9.4310.129.319.579.44
Market cap
40.95B45.02B40.28B35.8B30.18B
Enterprise value
42.67B46.74B41.84B37.26B31.33B
P/E ratio
27.8231.9733.3480.6315.89
Price to sales ratio
22.1525.6423.4621.4117.88
POCF ratio
91.41152.08101.2163.758.5
PFCF ratio
108.34204.62118.1274.4369.87
P/B Ratio
7.748.036.976.445.16
PTB ratio
7.748.036.976.445.16
EV to sales
23.0826.6224.3722.2818.56
Enterprise value over EBITDA
77.4493.188.64164.1462.16
EV to operating cash flow
95.24157.89105.1266.360.72
EV to free cash flow
112.88212.44122.6977.4672.52
Earnings yield
0.010.010.0100.02
Free cash flow yield
0.0100.010.010.01
Debt to equity
0.520.530.470.50.47
Debt to assets
0.260.270.250.260.25
Net debt to EBITDA
3.113.433.36.432.27
Current ratio
2.032.112.372.292.61
Interest coverage
20.4817.0415.965.5418.55
Income quality
1.220.841.325.061.09
Dividend Yield
00000
Payout ratio
0.170.190.220.590.14
Sales general and administrative to revenue
00000
Research and developement to revenue
0.060.070.070.070.07
Intangibles to total assets
0.450.440.440.420.41
Capex to operating cash flow
-0.16-0.26-0.14-0.14-0.16
Capex to revenue
-0.04-0.04-0.03-0.05-0.05
Capex to depreciation
-0.96-1.13-0.8-1.14-1.35
Stock based compensation to revenue
0.010.030.010.020.01
Graham number
22.3622.5221.1712.6727.07
ROIC
0.050.040.040.010.05
Return on tangible assets
0.060.060.050.020.08
Graham Net
-8.79-8.12-7.55-7.65-6.32
Working capital
1.92B2.14B2.28B2.27B2.58B
Tangible asset value
516M816M1B1.07B1.41B
Net current asset value
-1.45B-1.23B-1.06B-1.09B-732M
Invested capital
0.520.530.470.50.47
Average receivables
1.38B1.43B1.43B1.37B1.32B
Average payables
569M560M509.5M465.5M435M
Average inventory
1.02B1.07B1.11B1.09B1.05B
Days sales outstanding
68.3974.7873.4472.0868.83
Days payables outstanding
62.3761.6854.3640.1248.67
Days of inventory on hand
111.61126.89125.1895.15120.04
Receivables turnover
1.321.21.231.251.31
Payables turnover
1.441.461.662.241.85
Inventory turnover
0.810.710.720.950.75
ROE
0.070.060.050.020.08
Capex per share
-0.24-0.26-0.19-0.28-0.29

A Frequently Asked Questions

What is Agilent Technologies, Inc. stock symbol ?

Agilent Technologies, Inc. is a US stock , located in Santa clara of Ca and trading under the symbol A

Is Agilent Technologies, Inc. buy or a sell ?

8 stock analysts have 8 predictions with a medium analyst target price of $148.88. The lowest prediction is $105 and the highest is $170

What is A stock prediction ?

With a median analyst target price of $112.5, 2 stock analysts have made 2 forecasts in last 90 days. $105 is the lowest and $120 is the greatest projection.

What is Agilent Technologies, Inc. stock quote today ?

Agilent Technologies, Inc. stock price is $127.2 today.

Is Agilent Technologies, Inc. stock public?

Yes, Agilent Technologies, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap